HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frederic I Preffer Selected Research

Radiotherapy

7/2009Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frederic I Preffer Research Topics

Disease

4Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 07/2007
4Neoplasms (Cancer)
01/2020 - 11/2010
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2018 - 07/2009
2Lymphoma (Lymphomas)
10/2018 - 07/2005
2Inflammation (Inflammations)
12/2015 - 07/2003
2Graft vs Host Disease (Graft-Versus-Host Disease)
05/2014 - 07/2007
2Ovarian Neoplasms (Ovarian Cancer)
02/2012 - 11/2010
1Thrombocytopenia (Thrombopenia)
01/2020
1Anemia
01/2020
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020
1Febrile Neutropenia
01/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2018
1T-Cell Lymphoma (Lymphoma, T Cell)
10/2018
1Vasculitis (Vasculitides)
01/2016
1Dacryocystitis (Dacryoadenitis)
12/2015
1Immunoglobulin G4-Related Disease
12/2015
1Orbital Pseudotumor
12/2015
1Osteoporosis
06/2014
1Pathologic Complete Response
05/2014
1Colitis
12/2012
1Chronic Kidney Failure (Chronic Renal Failure)
12/2010
1Hyperplasia
09/2010
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2009
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2009
1Falciparum Malaria (Plasmodium falciparum Malaria)
03/2009
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2008
1Leukemia
07/2005
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2004
1Multiple Myeloma
01/2002

Drug/Important Bio-Agent (IBA)

2Chimeric Antigen ReceptorsIBA
01/2020 - 10/2018
2Surface Antigens (Surface Antigen)IBA
10/2018 - 11/2010
2CytokinesIBA
10/2018 - 07/2007
2AntigensIBA
10/2018 - 09/2004
2Epithelial Cell Adhesion MoleculeIBA
02/2012 - 11/2010
2Anti-Mullerian HormoneIBA
02/2012 - 11/2010
2Biological ProductsIBA
11/2010 - 01/2002
1Immunoconjugates (Immunoconjugate)IBA
01/2020
1Brentuximab VedotinIBA
01/2020
1MetalsIBA
01/2016
1Immunoglobulin G (IgG)IBA
12/2015
1Teriparatide (Parathar)FDA Link
06/2014
1Urate Oxidase (Uricase)IBA
05/2014
1Polysaccharides (Glycans)IBA
12/2012
1Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2012
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2010
1Proteoglycans (Proteoglycan)IBA
09/2010
1Protein Kinases (Protein Kinase)IBA
09/2010
1Anaplastic Lymphoma KinaseIBA
07/2009
1CD36 AntigensIBA
03/2009
1Sickle HemoglobinIBA
03/2009
1Dihydrotachysterol (AT 10)IBA
11/2008
1Monoclonal AntibodiesIBA
07/2007
1AntibodiesIBA
07/2005
1C-terminal binding proteinIBA
07/2003
1Leukotriene B4IBA
07/2003

Therapy/Procedure

2Therapeutics
01/2020 - 01/2013
1Drug Therapy (Chemotherapy)
01/2020
1Induction Chemotherapy
01/2020
1Hematopoietic Stem Cell Transplantation
05/2014
1Stem Cell Transplantation
05/2014
1Radiotherapy
07/2009
1Cell Transplantation
07/2007